Position in ABCL
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$13,101,758
+$5,337,108 QoQ
Shares Held
1,669,014
-25.0% QoQ
Ownership
0.544%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#13
of 150 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 92%
Shared 0%
None 8%
Common Shares in ABCL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $16,717,848,806 across 523 Biotechnology names. ABCL ranks #123 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
42,931,597 | $2,407,174,637 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,242,139 | $1,610,467,694 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
42,592,905 | $1,507,362,901 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,397,712 | $871,529,332 | |
| 5 | MRNA |
Moderna, Inc.
|
9,538,094 | $667,952,718 | |
| 6 | ARGX |
Argenx SE
|
643,123 | $596,670,219 | |
| 7 | TECH |
BIO-TECHNE Corp
|
6,374,717 | $450,373,747 | |
| 8 | INCY |
Incyte Corp
|
2,948,364 | $334,226,536 |
All Filings in ABCL
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,101,758 | 1,669,014 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $7,764,650 | 2,224,829 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $10,266,323 | 3,001,850 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $14,044,472 | 2,792,142 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $3,419,457 | 996,927 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $2,878,964 | 1,291,016 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $2,746,534 | 937,385 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $1,533,095 | 589,653 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $1,634,302 | 552,130 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $1,767,327 | 390,139 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $2,152,039 | 376,890 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $2,674,507 | 581,415 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $7,636,659 | 1,182,146 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $6,856,903 | 909,404 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $6,437,956 | 635,534 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $6,952,765 | 703,010 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $5,101,377 | 479,003 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $3,833,073 | 393,136 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $7,163,868 | 500,970 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $14,749,818 | 736,019 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $12,632,246 | 574,193 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $2,457,514 | 72,365 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $118,708 | 2,950 | Shares | Defined | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||